Lumira Ventures, Canadian health care and life sciences venture capital firm, has raised $255 million in capital commitments for its two funds.

The vehicles include Lumira Ventures IV, a $220 million fund, and a $35 million strategic venture fund, launched in partnership with an international pharmaceutical company.

Investors in the funds include pension plans, strategic corporate investors, Kensington Capital Partners, Fonds de Solidarité FTQ, Northleaf Capital Partners, among others.

With the latest capital infusion, the funds will enable the firm to found and build innovative healthcare companies in Canada and the U.S.